Characterization of hyperimmunoglobulins for prevention of maternofetal Cytomegalovirus transmission / vorgelegt von Matthias Stefan Schampera
| Medienart: |
E-Book |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
Tübingen: 2019 |
| Weitere Ausgaben: |
Erscheint auch als Druck-Ausgabe: Characterization of hyperimmunoglobulins for prevention of maternofetal Cytomegalovirus transmission |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Schampera, Matthias Stefan [VerfasserIn] |
|---|---|
| Hochschulschrift: |
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Hochschulschrift |
|---|
| Umfang: |
1 Online-Ressource (144 Seiten) |
|---|
| doi: |
10.15496/publikation-30772 |
|---|---|
| Weitere IDs: |
urn:nbn:de:bsz:21-dspace-893919 10900/89391 |
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
1666841919 |
|---|
| LEADER | 01000cam a2200265 4500 | ||
|---|---|---|---|
| 001 | 1666841919 | ||
| 003 | DE-627 | ||
| 005 | 20230426142301.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190605s2019 xx |||||om 00| ||eng c | ||
| 024 | 7 | |a urn:nbn:de:bsz:21-dspace-893919 |2 urn | |
| 024 | 7 | |a 10.15496/publikation-30772 |2 doi | |
| 024 | 7 | |a 10900/89391 |2 hdl | |
| 035 | |a (DE-627)1666841919 | ||
| 035 | |a (DE-599)KXP1666841919 | ||
| 035 | |a (OCoLC)1157887240 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 570 |a 610 |
| 100 | 1 | |a Schampera, Matthias Stefan |e verfasserin |0 (DE-588)1187860816 |0 (DE-627)1666842427 |4 aut | |
| 245 | 1 | 0 | |a Characterization of hyperimmunoglobulins for prevention of maternofetal Cytomegalovirus transmission |c vorgelegt von Matthias Stefan Schampera |
| 264 | 1 | |a Tübingen |c 2019 | |
| 300 | |a 1 Online-Ressource (144 Seiten) | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 502 | |b Dissertation |c Eberhard Karls Universität Tübingen |d 2019 | ||
| 650 | 0 | 7 | |0 (DE-588)4063597-1 |0 (DE-627)106127284 |0 (DE-576)209149493 |a Virologie |2 gnd |
| 650 | 0 | 7 | |0 (DE-588)4063605-7 |0 (DE-627)106127276 |0 (DE-576)209149515 |a Viruskrankheit |2 gnd |
| 650 | 0 | 7 | |0 (DE-588)4026626-6 |0 (DE-627)106287516 |0 (DE-576)208967338 |a Immunglobuline |2 gnd |
| 650 | 0 | 7 | |0 (DE-588)4053724-9 |0 (DE-627)104544732 |0 (DE-576)209105321 |a Schwangerschaft |2 gnd |
| 655 | 7 | |a Hochschulschrift |0 (DE-588)4113937-9 |0 (DE-627)105825778 |0 (DE-576)209480580 |2 gnd-content | |
| 710 | 2 | |a Eberhard Karls Universität Tübingen |e Grad-verleihende Institution |0 (DE-588)36187-2 |0 (DE-627)100833349 |0 (DE-576)190344806 |4 dgg | |
| 751 | |a Tübingen |0 (DE-588)4061147-4 |0 (DE-627)106136933 |0 (DE-576)209138351 |4 uvp | ||
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |a Schampera, Matthias Stefan |t Characterization of hyperimmunoglobulins for prevention of maternofetal Cytomegalovirus transmission |d Tübingen, 2019 |h 144 Seiten |w (DE-627)1666841811 |
| 856 | 4 | 0 | |u http://nbn-resolving.de/urn:nbn:de:bsz:21-dspace-893919 |q application/pdf |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u http://dx.doi.org/10.15496/publikation-30772 |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u http://hdl.handle.net/10900/89391 |x Resolving-System |z kostenfrei |3 Volltext |
| 912 | |a GBV_ILN_2001 | ||
| 912 | |a ISIL_DE-21 | ||
| 912 | |a SYSFLAG_1 | ||
| 912 | |a GBV_KXP | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a GBV_ILN_2403 | ||
| 912 | |a ISIL_DE-LFER | ||
| 951 | |a BO | ||
| 980 | |2 2001 |1 01 |x DE-21 |b 348166947X |c 00 |f --%%-- |d --%%-- |e --%%-- |j --%%-- |y l01 |z 05-06-19 | ||
| 980 | |2 2403 |1 01 |x DE-LFER |b 3498499041 |c 00 |f --%%-- |d --%%-- |e n |j --%%-- |y l01 |z 27-07-19 | ||
| 981 | |2 2001 |1 01 |x DE-21 |r http://nbn-resolving.de/urn:nbn:de:bsz:21-dspace-893919 | ||
| 981 | |2 2403 |1 01 |x DE-LFER |r http://dx.doi.org/10.15496/publikation-30772 | ||
| 982 | |2 2001 |1 01 |x DE-21 |8 00 |s s |a Human Cytomegalovirus | ||
| 982 | |2 2001 |1 01 |x DE-21 |8 01 |s s |a HCMV | ||
| 982 | |2 2001 |1 01 |x DE-21 |8 02 |s s |a Hyperimmunoglobulin | ||
| 982 | |2 2001 |1 01 |x DE-21 |8 03 |s s |a HIG treatment | ||
| 982 | |2 2001 |1 01 |x DE-21 |8 04 |s s |a Pregnant women | ||
| 982 | |2 2001 |1 01 |x DE-21 |8 05 |s s |a Pentameric complex | ||
| 982 | |2 2001 |1 01 |x DE-21 |8 06 |s s |a gHgLUL128-131 | ||
| 982 | |2 2001 |1 01 |x DE-21 |8 07 |s s |a Neutralizing antibodies | ||
| 982 | |2 2001 |1 01 |x DE-21 |8 08 |s s |a IgG subclass 3 | ||
| 982 | |2 2001 |1 01 |x DE-21 |8 09 |s s |a IFN-gamma | ||